Literature DB >> 18563684

[Surgical therapy for malignant pleural effusions].

C Ludwig1, E Stoelben.   

Abstract

Symptomatic malignant pleural effusions are common in patients with neoplastic disease (50 %). Frequently, they are a sign of advanced disease. These patients have an average life expectancy of 3 to 12 months. The therapeutic aim should be an efficient treatment with a short hospital stay. Chest tube drainage gives rapid relief of symptoms and information on the expansion of the lungs. When complete expansion of the lung is possible, VATS insufflation of talc is recommended. Talc is the most effective sclerosant (80 %) followed by doxycycline (70 %). VATS pleurodesis has a higher complication rate but is more effective than a talc slurry instilled through the chest tube. When the lung is trapped, long-term indwelling pleural drainage and pleuroperitoneal shunts are alternatives.

Entities:  

Mesh:

Year:  2008        PMID: 18563684     DOI: 10.1055/s-2008-1076788

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  3 in total

1.  Prolonged pleural catheters in the management of pleural effusions due to breast cancer.

Authors:  Ozkan Demirhan; Cetin Ordu; Alper Toker
Journal:  J Thorac Dis       Date:  2014-02       Impact factor: 2.895

Review 2.  The treatment of pleural carcinosis with malignant pleural effusion.

Authors:  Michael Ried; Hans-Stefan Hofmann
Journal:  Dtsch Arztebl Int       Date:  2013-05       Impact factor: 5.594

3.  Postoperative outcome after palliative treatment of malignant pleural effusion.

Authors:  Till Markowiak; Michael Ried; Christian Großer; Hans-Stefan Hofmann; Ludger Hillejan; Erich Hecker; Michael Semik; Thomas Lesser; Christian Kugler; Sven Seifert; Robert Scheubel
Journal:  Thorac Cancer       Date:  2022-06-15       Impact factor: 3.223

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.